← Leaderboards
Elisabeth D Martinez
Ut Southwestern Medical Center
$4,685,595
Attributed
$5,631,546
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $661.7K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,631,546 · 9
By mechanism
R01$1,797,544 · 1
R21$1,499,943 · 4
R33$1,454,652 · 1
K22$458,186 · 1
R03$309,819 · 1
P50$111,402 · 1
Top collaborators
- Ivan D'Orso5 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Deepak Nijhawan$7,364,715
- Richard C Wang$4,906,273
- Amit Singal$17,388,983
- Marcel Bernard Mettlen$2,152,886
- Michael Buszczak$10,005,304
Others in their field
Top investigators on “Epigenetic Process”
- James E. Gern · University Of Wisconsin-Madison$115,652,679
- Richard A Gibbs · Baylor College Of Medicine$86,065,396
- Lisa P Jacobson · Johns Hopkins University$67,179,266
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$58,922,015
- Leonardo Trasande · New York University School Of Medicine$52,109,279
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$47,855,284
Research focus
Epigenetic ProcessEnzymesCellsIn VivoCell LineGenesHistonesGrowthMalignant NeoplasmsTumorPathway InteractionsEventGene ExpressionCell DeathGenomicsPharmaceutical PreparationsChromatinMammalian CellMalignant Neoplasm Of LungCancer CellFoundationsBaseAffectMolecular
Grant awards (26)
Jumonji enzyme action in hepatocellular carcinoma onset$230,010
R21 · FY2025 · CA · contact PI
Jumonji KDM4A drives targetable oncogenic programs in small cell lung cancer$191,675
R21 · FY2025 · CA · contact PI
Career Enhancement Program$111,402
P50 · FY2025 · CA · contact PI
Jumonji enzyme action in hepatocellular carcinoma onset$191,675
R21 · FY2024 · CA · contact PI
Post-translational modifications control JARID enzyme activity during DNA damage$82,000
R03 · FY2024 · CA · contact PI
Post-translational modifications control JARID enzyme activity during DNA damage$74,864
R03 · FY2024 · CA · contact PI
Post-translational modifications control JARID enzyme activity during DNA damage$82,000
R03 · FY2023 · CA · contact PI
Post-translational modifications control JARID enzyme activity during DNA damage$70,955
R03 · FY2023 · CA · contact PI
Epigenetic reprogramming of the malaria parasite$204,583
R21 · FY2021 · AI · contact PI
Epigenetic reprogramming of the malaria parasite$244,750
R21 · FY2020 · AI · contact PI
Novel small molecules to reactivate latent HIV and sensitize to anti-viral therapies$484,884
R33 · FY2018 · AI
Novel small molecules to reactivate latent HIV and sensitize to anti-viral therapies$484,884
R33 · FY2017 · AI
Novel small molecules to reactivate latent HIV and sensitize to anti-viral therapies$484,884
R33 · FY2016 · AI
Novell small molecules to reactivate latent HIV and sensitize to anti-viral therapies$218,625
R21 · FY2015 · AI
Characterization of the biological activities of novel epigenetic modulators$310,426
R01 · FY2014 · CA · contact PI
Novell small molecules to reactivate latent HIV and sensitize to anti-viral therapies$218,625
R21 · FY2014 · AI
Characterization of the biological activities of novel epigenetic modulators$132,638
R01 · FY2014 · CA · contact PI
Characterization of the biological activities of novel epigenetic modulators$300,826
R01 · FY2013 · CA · contact PI
Characterization of the biological activities of novel epigenetic modulators$86,389
R01 · FY2013 · CA · contact PI
Characterization of the biological activities of novel epigenetic modulators$319,356
R01 · FY2012 · CA · contact PI
Characterization of the biological activities of novel epigenetic modulators$319,021
R01 · FY2011 · CA · contact PI
Characterization of the biological activities of novel epigenetic modulators$328,888
R01 · FY2010 · CA · contact PI
Characterization of small molecule inhibitors of HDACs and DNMTs$60,500
K22 · FY2009 · CA · contact PI
Characterization of small molecule inhibitors of HDACs and DNMTs$136,596
K22 · FY2008 · CA · contact PI
Characterization of small molecule inhibitors of HDACs and DNMTs$134,190
K22 · FY2007 · CA · contact PI
Characterization of small molecule inhibitors of HDACs and DNMTs$126,900
K22 · FY2006 · CA · contact PI